Non-covalent BTK inhibitor found effective in some heavily pretreated patients with CLL.
Increased Risk of Stroke, Bleeding and Atrial Fibrillation in Older CLL Patients Treated with Ibrutinib
A new study found older adults with CLL have increased risk of adverse events such as atrial fibrillation.
These Are the ASCO 2019 Abstracts That Will Make a Difference
What research abstracts presented at this year’s American Society of Clinical Oncology annual meeting will have the biggest potential impact on clinical practice? Cleveland Clinic Cancer Center physicians make their picks.
Research Sheds Light on Ethnic Discrepancies in CLL
Learn more about a Cleveland Clinic study led by oncologist Dr. Brian Hill, which links ethnicity-specific genes to chronic lymphocytic leukemia.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy